Journal of General Virology, Vol 80, 691-699, Copyright © 1999 by Society for General Microbiology

ARTICLES

Genetic diversity of equine arteritis virus

T Stadejek, H Bjorklund, CR Bascunana, IM Ciabatti, MT Scicluna, D Amaddeo, WH McCollum, GL Autorino, PJ Timoney, DJ Paton, B Klingeborn and S Belak
Department of Virology, The National Veterinary Institute, Biomedical Center, Uppsala, Sweden.

Equine arteritis viruses (EAV) from Europe and America were compared by phylogenetic analysis of 43 isolates obtained over four decades. An additional 22 virus sequences were retrieved from GenBank. Fragments of the glycoprotein G(L) and the replicase genes were amplified by RT-PCR, prior to sequencing and construction of phylogenetic trees. The trees revealed many distinctive lineages, consistent with prolonged diversification within geographically separated host populations. Two large groups and five subgroups were distinguished. Group I consisted mainly of viruses from North America, whilst group II consisted mainly of European isolates. In most instances, where the geographic origin of the viruses appeared to be at variance with the phylogenetically predicted relationships, the horses from which the viruses were recovered had been transported between Europe and America or vice versa. Analysis of the replicase gene revealed similar phylogenetic relationships although not all of the groups were as clearly defined. Virus strains CH1 (Switzerland, 1964) and S1 (Sweden, 1989) represented separate 'outgroups' based on analysis of both genomic regions. The results of this study confirm the value of the G(L) gene of EAV for estimating virus genetic diversity and as a useful tool for tracing routes by which EAV is spread. In addition, computer-assisted predictions of antigenic sites on the G(L) protein revealed considerable variability among the isolates, especially with respect to regions associated with neutralization domains.

This article has been cited by other articles:

				E. VAN DEN BORN, A. P. GULTYAEV, and E. J. SNIJDER Secondary structure and function of the 5'-proximal region of the equine arteritis virus RNA genome RNA, March 1, 2004; 10(3): 424 - 437. [Abstract] [Full Text] [PDF]

				U. B. R. Balasuriya, J. F. Hedges, V. L. Smalley, A. Navarrette, W. H. McCollum, P. J. Timoney, E. J. Snijder, and N. J. MacLachlan Genetic characterization of equine arteritis virus during persistent infection of stallions J. Gen. Virol., February 1, 2004; 85(2): 379 - 390. [Abstract] [Full Text] [PDF]

				J. Castillo-Olivares, R. Wieringa, T. Bakonyi, A. A. F. de Vries, N. J. Davis-Poynter, and P. J. M. Rottier Generation of a Candidate Live Marker Vaccine for Equine Arteritis Virus by Deletion of the Major Virus Neutralization Domain J. Virol., August 1, 2003; 77(15): 8470 - 8480. [Abstract] [Full Text] [PDF]

				C. Jeronimo and D. Archambault Importance of M-Protein C Terminus as Substrate Antigen for Serodetection of Equine Arteritis Virus Infection Clin. Vaccine Immunol., May 1, 2002; 9(3): 698 - 703. [Abstract] [Full Text] [PDF]

				J. Castillo-Olivares, A. A. F. de Vries, M. J. B. Raamsman, P. J. M. Rottier, K. Lakhani, D. Westcott, J. P. Tearle, J. L. N. Wood, J. A. Mumford, D. Hannant, et al. Evaluation of a prototype sub-unit vaccine against equine arteritis virus comprising the entire ectodomain of the virus large envelope glycoprotein (GL): induction of virus-neutralizing antibody and assessment of protection in ponies J. Gen. Virol., October 1, 2001; 82(10): 2425 - 2435. [Abstract] [Full Text] [PDF]

				E. Weiland, S. Bolz, F. Weiland, W. Herbst, M. J. B. Raamsman, P. J. M. Rottier, and A. A. F. De Vries Monoclonal Antibodies Directed against Conserved Epitopes on the Nucleocapsid Protein and the Major Envelope Glycoprotein of Equine Arteritis Virus J. Clin. Microbiol., June 1, 2000; 38(6): 2065 - 2075. [Abstract] [Full Text]